Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Jade Biosciences, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 64
- +7 vs. Q3 2023
- Shares held
- 28.2M
- +323.5K (+1.2%) vs. Q3 2023
- Total value
- $637.8M
- +$259.7M (+68.7%) vs. Q3 2023
- New holders
- 11
- 21 more added
- Sold out
- 4
- 17 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $187.0M | 2.92% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $85.1M | 4.76% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $49.8M | 5.52% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $46.1M | 5.50% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,680,517 | $38.0M | 0.43% | −282,962−14.4% | Reduced |
| Cormorant Asset Management, LP | 1,211,696 | $27.4M | 1.31% | −350,000−22.4% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $27.3M | 1.46% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,058,209 | $23.9M | 0.29% | −129,409−10.9% | Reduced |
| Great Point Partners LLC | 1,037,690 | $23.5M | 4.00% | −53,543−4.9% | Reduced |
| OrbiMed Advisors LLC | 756,930 | $17.1M | 0.34% | 00.0% | Unchanged |
| BlackRock Inc. | 727,454 | $16.5M | 0.00% | +44,673+6.5% | Added |
| Vanguard Group Inc | 626,831 | $14.2M | 0.00% | +27,729+4.6% | Added |
| FMR LLC | 537,486 | $12.2M | 0.00% | +7,942+1.5% | Added |
| Point72 Asset Management, L.P. | 441,474 | $9.99M | 0.03% | +441,474 | New |
| Octagon Capital Advisors LP | 403,685 | $9.14M | 1.46% | −93,685−18.8% | Reduced |
| Vestal Point Capital, LP | 400,000 | $9.05M | 0.96% | +400,000 | New |
| Geode Capital Management, LLC | 276,895 | $6.27M | 0.00% | +27,087+10.8% | Added |
| State Street Corp | 214,027 | $4.84M | 0.00% | +32,523+17.9% | Added |
| Ghost Tree Capital, LLC | 210,000 | $4.75M | 2.74% | +8,803+4.4% | Added |
| Paradigm Biocapital Advisors LP | 143,235 | $3.24M | 0.15% | +143,235 | New |
| Ensign Peak Advisors, Inc | 122,257 | $2.77M | 0.01% | +107,257+715.0% | Added |
| Hudson Bay Capital Management LP | 103,000 | $2.33M | 0.02% | +103,000 | New |
| Northern Trust Corp | 99,527 | $2.25M | 0.00% | −10,916−9.9% | Reduced |
| Nantahala Capital Management, LLC | 91,188 | $2.06M | 0.21% | −3,812−4.0% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $1.15M | 0.01% | 00.0% | Unchanged |
| Eversept Partners, LP | 50,242 | $1.14M | 0.11% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 47,936 | $1.08M | 0.68% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 40,047 | $906.3K | 0.00% | +3,737+10.3% | Added |
| Bank of New York Mellon Corp | 36,558 | $827.3K | 0.00% | +9,146+33.4% | Added |
| Fred Alger Management, LLC | 36,478 | $825.5K | 0.00% | +11,731+47.4% | Added |
| Morgan Stanley | 35,052 | $793.2K | 0.00% | +15,999+84.0% | Added |
| Charles Schwab Investment Management Inc | 29,542 | $668.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22,698 | $513.7K | 0.00% | +12,393+120.3% | Added |
| Alps Advisors Inc | 18,718 | $423.6K | 0.00% | −1,677−8.2% | Reduced |
| Parkwood LLC | 15,786 | $357.0K | 0.06% | −4,867−23.6% | Reduced |
| Barclays PLC | 15,394 | $348.4K | 0.00% | +11,548+300.3% | Added |
| Dimensional Fund Advisors LP | 14,957 | $338.9K | 0.00% | −5,589−27.2% | Reduced |
| Rhumbline Advisers | 14,157 | $320.4K | 0.00% | +164+1.2% | Added |
| Takeda Pharmaceutical Co Ltd | 13,580 | $307.3K | 0.09% | +13,580 | New |
| Jane Street Group, LLC | 13,106 | $296.6K | 0.00% | +13,106 | New |
| Alliancebernstein L.P. | 13,100 | $296.5K | 0.00% | +650+5.2% | Added |
| UBS Group AG | 12,241 | $277.0K | 0.00% | +1,027+9.2% | Added |
| Eventide Asset Management, LLC | 12,178 | $275.6K | 0.00% | +12,178 | New |
| Golden State Equity Partners | 10,880 | $246.2K | 0.06% | +350+3.3% | Added |
| Two Sigma Investments, LP | 9,760 | $220.9K | 0.00% | −2,044−17.3% | Reduced |
| HRT Financial LP | 9,433 | $213.0K | 0.00% | +9,433 | New |
| JPMorgan Chase & Co | 7,476 | $169.2K | 0.00% | +57+0.8% | Added |
| EntryPoint Capital, LLC | 6,133 | $138.8K | 0.13% | +6,133 | New |
| American International Group, Inc. | 5,556 | $125.7K | 0.00% | −23−0.4% | Reduced |
| MetLife Investment Management | 5,228 | $118.3K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 4,985 | $112.8K | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 4,303 | $97.4K | 0.00% | −15−0.3% | Reduced |
| Royal Bank of Canada | 3,475 | $79.0K | 0.00% | +2,075+148.2% | Added |
| Wells Fargo & Company | 2,914 | $65.9K | 0.00% | +660+29.3% | Added |
| STRS Ohio | 2,300 | $52.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,095 | $47.4K | 0.00% | +1,882+883.6% | Added |
| California State Teachers Retirement System | 1,840 | $41.6K | 0.00% | −9,172−83.3% | Reduced |
| Legal & General Group Plc | 1,666 | $37.7K | 0.00% | −6,026−78.3% | Reduced |
| Amalgamated Bank | 1,432 | $32.0K | 0.00% | −103−6.7% | Reduced |
| Tower Research Capital LLC (TRC) | 922 | $20.9K | 0.00% | −518−36.0% | Reduced |
| Ameritas Investment Partners, Inc. | 772 | $17.5K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 701 | $15.9K | 0.00% | 00.0% | Unchanged |
| Fortitude Family Office, LLC | 416 | $9.41K | 0.01% | +416 | New |
| GAMMA Investing LLC | 80 | $1.54K | 0.00% | +80 | New |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −53,365−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −21,201−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,644−100.0% | Sold out |
| OUP Management Co., LLC | – | – | – | – | Not filed |